The type 2 cannabinoid receptor (CB2) protects against age-related osteoporosis by affecting bone formation and CB2 agonists exhibit anabolic activity in vivo

✍ Scribed by A. Sophocleous⁎; E. Landao-Bassonga; R. van't Hof; S.H. Ralston; A.I. Idris

• Book ID: 116321602
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 51 KB
• Volume: 44
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2009.03.059